Abstract

QUINOXALINE CHRONILES: UNLOCKING A NEW PATHWAY TO PAIN RELIEF

Dr. P. R. Logeshkumar*, Dr. S. K. Senthilkumar, A. Infant Benitta, R. Janarthanan, M. Jayashree, S. Jeeva, S. Jeevanandham

Abstract

Quinoxaline is a nitrogen-containing heterocyclic compound consisting of a fused benzene and pyrazine ring, known for its wide range of pharmacological activities. Due to its stable aromatic structure and modifiable functional groups, quinoxaline has attracted significant attention in medical chemistry. Various quinoxaline derivatives have been reported to exhibit antimicrobial, anti-inflammatory, anticancer, and analgesic activities. The analgesic effect is mainly associated with inhibition of inflammatory mediators and modulation of pain pathways. The present project involves the synthesis of novel quinoxaline derivatives with the aim of enhancing analgesic activity.

Keywords: The analgesic effect is mainly associated with inhibition of inflammatory mediators and modulation of pain pathways.